As of 4:14pm ET
| +1.09 / +0.79%|
The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 125.00, with a high estimate of 229.00 and a low estimate of 93.00. The median estimate represents a -10.31% decrease from the last price of 139.37.
The current consensus among 13 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.